Table 2.
Antifungal susceptibility testing of various Candida spp.
| Antifungal agents | Candida spp. | Total (N = 100) | |||
|---|---|---|---|---|---|
| C. albicans (N = 56) | C. tropicalis (N = 20) | C. krusei (N = 10) | C. glabrata (N = 14) | ||
| Ketoconazole | |||||
| S | 4 (7.2%) | 0 (0%) | 2 (20%) | 0 (0%) | 6 (6%) |
| SDD | 2 (3.6%) | 4 (20%) | 0 (0%) | 2 (14.3%) | 8 (8%) |
| R | 50 (89.3%) | 16 (80%) | 8 (80%) | 12 (85.8%) | 86 (86%) |
| Fluconazole | |||||
| S | 40 (71.5%) | 12 (60%) | 4 (40%) | 8 (57.2%) | 64 (64%) |
| SDD | 6 (10.8%) | 4 (20%) | 6 (60%) | 0 (0%) | 16 (16%) |
| R | 10 (17.9%) | 4 (20%) | 0 (0%) | 6 (42.9%) | 20 (20%) |
| Miconazole | |||||
| S | 30 (53.6%) | 10 (50%) | 2 (20%) | 2 (14.2%) | 44 (44%) |
| SDD | 18 (32.2%) | 8 (40%) | 6 (60%) | 12 (85.8%) | 44 (44%) |
| R | 8 (14.3%) | 2 (10%) | 2 (20%) | 0 (0%) | 12 (12%) |
| Clotrimazole | |||||
| S | 44 (78.6%) | 16 (80%) | 10 (100%) | 12 (85.8%) | 82 (82%) |
| SDD | 8 (14.3%) | 4 (20%) | 0 (0%) | 0 (0%) | 16 (16%) |
| R | 4 (7.2%) | 0 (0%) | 0 (0%) | 2 (14.2%) | 6 (6%) |